Tracks blood thinner effects in people with atrial fibrillation over time
Observes complications of long-term blood thinners in adults with atrial fibrillation.
Plain-language title generated from the registry record
Registry title: REGistry of Long-term AnTithrombotic TherApy-2
Key facts
- Where
- Moscow, RussiaSee the site
Where in Russia
- National Medical Research Center for Cardiology, Ministry of Health of Russian FederationMoscow, RussiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Trial code
- NCT04347187
- Record updated
- 1 May 2026
- Original description
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillationRead full original descriptionShow less
Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Atrial Fibrillation
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation
Inclusion: Documented atrial fibrillation with CHA2DS2VASC > 1.
Exclusion: Subjects who are unwilling or unable to provide informed consent. ACS within 12 months before inclusion Severe CHF (NYHA IV) Stroke within 6 months before inclusion Severe liver or muscle disease Severe kidney disease / renal failure with creatinine > 3 mg/dl Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention.